Giovanni Lapadula

6.9k total citations
191 papers, 4.5k citations indexed

About

Giovanni Lapadula is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Giovanni Lapadula has authored 191 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Rheumatology, 36 papers in Hematology and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Giovanni Lapadula's work include Rheumatoid Arthritis Research and Therapies (75 papers), Systemic Lupus Erythematosus Research (42 papers) and Autoimmune and Inflammatory Disorders Research (35 papers). Giovanni Lapadula is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (75 papers), Systemic Lupus Erythematosus Research (42 papers) and Autoimmune and Inflammatory Disorders Research (35 papers). Giovanni Lapadula collaborates with scholars based in Italy, United States and Japan. Giovanni Lapadula's co-authors include Florenzo Iannone, Luca Cantarini, Giuseppe Lopalco, C. Scioscia, Maria Grazia Anelli, Mauro Galeazzi, M. Covelli, Gianfranco Ferraccioli, Roberto Caporali and Leonardo Punzi and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Giovanni Lapadula

185 papers receiving 4.4k citations

Peers

Giovanni Lapadula
Giovanni Lapadula
Citations per year, relative to Giovanni Lapadula Giovanni Lapadula (= 1×) peers Éric Toussirot

Countries citing papers authored by Giovanni Lapadula

Since Specialization
Citations

This map shows the geographic impact of Giovanni Lapadula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Lapadula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Lapadula more than expected).

Fields of papers citing papers by Giovanni Lapadula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Lapadula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Lapadula. The network helps show where Giovanni Lapadula may publish in the future.

Co-authorship network of co-authors of Giovanni Lapadula

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Lapadula. A scholar is included among the top collaborators of Giovanni Lapadula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Lapadula. Giovanni Lapadula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitale, Antonio, Stefano Alivernini, Roberto Caporali, et al.. (2023). From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”. Journal of Clinical Medicine. 12(2). 527–527. 1 indexed citations
2.
Ceccarelli, Fulvia, Marcello Govoni, Matteo Piga, et al.. (2022). Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium. Journal of Clinical Medicine. 11(20). 6016–6016. 15 indexed citations
3.
Salaffi, Fausto, Alessandra Alciati, Giulia Cassone, et al.. (2022). Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium”. Journal of Clinical Medicine. 11(24). 7537–7537. 4 indexed citations
4.
5.
Costa, Luisa, Roberta Ramonda, Augusta Ortolan, et al.. (2019). Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment. Clinical Rheumatology. 38(9). 2355–2362. 14 indexed citations
6.
Sarzi‐Puttini, Piercarlo, Paolo Angelo Cortesi, Roberto Giacomelli, et al.. (2017). THU0634 Comparing preferences of patients with rheumatic diseases, of rheumatologists, nurses and pharmacists toward the treatment of rheumatic diseases with biological agents: results from the cara study. Annals of the Rheumatic Diseases. 76. 445–445. 1 indexed citations
7.
Vitale, Antonio, Giacomo Emmi, Giuseppe Lopalco, et al.. (2017). Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease. Clinical Rheumatology. 36(9). 2063–2069. 33 indexed citations
8.
Iannone, Florenzo, Marilina Tampoia, Margherita Giannini, et al.. (2016). Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.. PubMed. 34(3). 424–9. 17 indexed citations
9.
Crincoli, Vito, et al.. (2016). Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study. International Journal of Molecular Sciences. 17(7). 1189–1189. 65 indexed citations
10.
Cacciapaglia, Fabio, Maria Grazia Anelli, Daniela Rizzo, et al.. (2016). Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients. Reumatismo. 67(3). 97–102. 14 indexed citations
11.
Morgese, Maria Grazia, Susanna Esposito, Giuseppe Lopalco, et al.. (2015). Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa. Medicine. 94(42). e1528–e1528. 48 indexed citations
12.
Iannone, Florenzo, Giuseppe Lopalco, Luca Cantarini, Mauro Galeazzi, & Giovanni Lapadula. (2015). Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis. Clinical Rheumatology. 35(1). 19–23. 10 indexed citations
13.
Vitale, Antonio, Donato Rigante, Giuseppe Lopalco, et al.. (2014). Serum amyloid-A in Behçet’s disease. Clinical Rheumatology. 33(8). 1165–1167. 14 indexed citations
14.
Nigro, Angelo, et al.. (2011). Sarcoidosis presenting with Raynaud’s syndrome: a case report. Reumatismo. 56(4). 278–81. 2 indexed citations
15.
Bombardieri, Stefano, Gianfranco Ferraccioli, Cássia Ferri, et al.. (2009). La rivoluzione copernicana nella terapia dell'artrite reumatoide: il contributo degli anti-TNFalpha.. Reumatismo. 61(1). 1–23. 3 indexed citations
16.
Maggi, Paolo, et al.. (2008). Functional Impairments of Microcirculation in HIV-Positive Patients: A Laser Doppler Fluxometry-Based Investigation. HIV Clinical Trials. 9(6). 428–433. 6 indexed citations
17.
Giannelli, Gianluigi, Florenzo Iannone, Felice Marinosci, et al.. (2006). Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis.. PubMed. 23(6). 867–72. 1 indexed citations
18.
Salaffi, Fausto, G Leardini, B Canesi, et al.. (2003). Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis and Cartilage. 11(8). 551–560. 248 indexed citations
19.
Grassi, Walter, Giovanni Lapadula, Raffaele Scarpa, et al.. (1995). IL FENOMENO DI RAYNAUD: LINEAMENTI CLINICI E DEMOGRAFICI. Reumatismo. 47(4). 269–279.
20.
Cantatore, F. P., Francesco Benazzo, Doménico Ribatti, et al.. (1988). Early alteration of synovial membrane in osteoarthrosis. Clinical Rheumatology. 7(2). 214–219. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026